China trial shows Gilead’s drug does not show benefits in COVID-19 patients: Lancet

Gilead Sciences Inc’s experimental drug remdesivir does not speed up recovery from COVID-19 compared with placebo in critically-ill, hospitalised patients, according to data from a trial in China …
( read original story …)